DAVIDE CAMPARI-MILANO NV (CPR.MI) Fundamental Analysis & Valuation

BIT:CPR • NL0015435975

Current stock price

6.642 EUR
+0.07 (+1.07%)
Last:

This CPR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CPR.MI Profitability Analysis

1.1 Basic Checks

  • In the past year CPR was profitable.
  • CPR had a positive operating cash flow in the past year.
  • Each year in the past 5 years CPR has been profitable.
  • In the past 5 years CPR always reported a positive cash flow from operatings.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • The Return On Assets of CPR (4.27%) is better than 74.07% of its industry peers.
  • CPR has a Return On Equity (8.97%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of CPR (6.57%) is better than 66.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 7.49%.
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROIC 6.57%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CPR has a Profit Margin of 11.35%. This is in the better half of the industry: CPR outperforms 66.67% of its industry peers.
  • CPR's Profit Margin has been stable in the last couple of years.
  • CPR has a better Operating Margin (19.74%) than 66.67% of its industry peers.
  • CPR's Operating Margin has improved in the last couple of years.
  • CPR has a better Gross Margin (60.31%) than 88.89% of its industry peers.
  • CPR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CPR.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
  • Compared to 1 year ago, CPR has less shares outstanding
  • CPR has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CPR has an improved debt to assets ratio.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 2.71 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.71, CPR is doing good in the industry, outperforming 74.07% of the companies in the same industry.
  • The Debt to FCF ratio of CPR is 6.60, which is on the high side as it means it would take CPR, 6.60 years of fcf income to pay off all of its debts.
  • CPR's Debt to FCF ratio of 6.60 is fine compared to the rest of the industry. CPR outperforms 70.37% of its industry peers.
  • A Debt/Equity ratio of 0.59 indicates that CPR is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.59, CPR is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Altman-Z 2.71
ROIC/WACC0.99
WACC6.65%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 2.22 indicates that CPR has no problem at all paying its short term obligations.
  • CPR's Current ratio of 2.22 is amongst the best of the industry. CPR outperforms 81.48% of its industry peers.
  • CPR has a Quick Ratio of 2.22. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.96, CPR belongs to the top of the industry, outperforming 85.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 0.96
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CPR.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 66.22% over the past year.
  • Measured over the past years, CPR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.04% on average per year.
  • The Revenue has decreased by -0.60% in the past year.
  • Measured over the past years, CPR shows a quite strong growth in Revenue. The Revenue has been growing by 11.48% on average per year.
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%

3.2 Future

  • Based on estimates for the next years, CPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.76% on average per year.
  • CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.30% yearly.
EPS Next Y4.41%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
EPS Next 5Y18.76%
Revenue Next Year0.49%
Revenue Next 2Y2.55%
Revenue Next 3Y3.39%
Revenue Next 5Y3.3%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0 0 0 0
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

3

4. CPR.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 22.90 indicates a rather expensive valuation of CPR.
  • CPR's Price/Earnings is on the same level as the industry average.
  • CPR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.53.
  • With a Price/Forward Earnings ratio of 21.07, CPR is valued on the expensive side.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CPR.
  • CPR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 37.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.9
Fwd PE 21.07
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CPR.
  • CPR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 21.06
EV/EBITDA 13.22
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CPR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.19
PEG (5Y)1.9
EPS Next 2Y8.37%
EPS Next 3Y9.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CPR.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.51%, CPR has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.76, CPR is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.82, CPR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.51%

5.2 History

  • The dividend of CPR decreases each year by -0.23%.
Dividend Growth(5Y)-0.23%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 22.52% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP22.52%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CPR.MI Fundamentals: All Metrics, Ratios and Statistics

DAVIDE CAMPARI-MILANO NV

BIT:CPR (4/17/2026, 11:48:10 AM)

6.642

+0.07 (+1.07%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners21.27%
Inst Owner ChangeN/A
Ins Owners50.82%
Ins Owner ChangeN/A
Market Cap8.18B
Revenue(TTM)3.05B
Net Income(TTM)346.30M
Analysts73.33
Price Target7.29 (9.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.51%
Yearly Dividend0.04
Dividend Growth(5Y)-0.23%
DP22.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.58%
PT rev (3m)3.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.73%
EPS NY rev (3m)-3.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.8%
Revenue NY rev (3m)-2.15%
Valuation
Industry RankSector Rank
PE 22.9
Fwd PE 21.07
P/S 2.68
P/FCF 21.06
P/OCF 11.89
P/B 2.12
P/tB 20.62
EV/EBITDA 13.22
EPS(TTM)0.29
EY4.37%
EPS(NY)0.32
Fwd EY4.75%
FCF(TTM)0.32
FCFY4.75%
OCF(TTM)0.56
OCFY8.41%
SpS2.48
BVpS3.14
TBVpS0.32
PEG (NY)5.19
PEG (5Y)1.9
Graham Number4.52368 (-31.89%)
Profitability
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROCE 8.89%
ROIC 6.57%
ROICexc 7.34%
ROICexgc 17.16%
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
FCFM 12.73%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
ROICexc(3y)7.81%
ROICexc(5y)8.35%
ROICexgc(3y)19.64%
ROICexgc(5y)24.18%
ROCE(3y)9.45%
ROCE(5y)9.92%
ROICexgc growth 3Y-14.23%
ROICexgc growth 5Y-7.25%
ROICexc growth 3Y-6.36%
ROICexc growth 5Y1.27%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Debt/EBITDA 3.02
Cap/Depr 201.82%
Cap/Sales 9.81%
Interest Coverage 6.43
Cash Conversion 91.62%
Profit Quality 112.13%
Current Ratio 2.22
Quick Ratio 0.96
Altman-Z 2.71
F-Score8
WACC6.65%
ROIC/WACC0.99
Cap/Depr(3y)282.75%
Cap/Depr(5y)284.75%
Cap/Sales(3y)11.87%
Cap/Sales(5y)11.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
EPS Next Y4.41%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
EPS Next 5Y18.76%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
Revenue Next Year0.49%
Revenue Next 2Y2.55%
Revenue Next 3Y3.39%
Revenue Next 5Y3.3%
EBIT growth 1Y1.65%
EBIT growth 3Y2.34%
EBIT growth 5Y14.68%
EBIT Next Year24.97%
EBIT Next 3Y12.76%
EBIT Next 5Y19.58%
FCF growth 1Y84.55%
FCF growth 3Y149.17%
FCF growth 5Y15.69%
OCF growth 1Y2.55%
OCF growth 3Y21.81%
OCF growth 5Y20.37%

DAVIDE CAMPARI-MILANO NV / CPR.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?

ChartMill assigns a fundamental rating of 5 / 10 to CPR.MI.


What is the valuation status for CPR stock?

ChartMill assigns a valuation rating of 3 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.


How profitable is DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?

DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 7 / 10.


What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 22.9 and the Price/Book (PB) ratio is 2.12.


Can you provide the expected EPS growth for CPR stock?

The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 4.41% in the next year.